The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...
“Commonly known as the stomach flu, norovirus has been around forever, and has become the leading cause of gastroenteritis or ...
The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.
In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...
The number of layoffs in the U.S. pharmaceutical industry exceeded 14,000 last year, a 9% increase from 2023 ...
Norovirus, often erroneously called the "stomach flu," sickens an estimated 21 million Americans and 685 million people ...
Moderna shares soared as investors placed bets that the pharmaceutical giant’s development of an H5N1 bird flu vaccine could ...
In a report released on January 7, Luca Issi from RBC Capital maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...
2d
Zacks.com on MSNModerna (MRNA) Stock Jumps 11.7%: Will It Continue to Soar?Moderna (MRNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
2d
Stocktwits on MSNModerna Stock Tumbles After Best Day In 7 Months, But Retail Confidence Holds FirmShares of Moderna Inc. fell over 8% on Wednesday afternoon, paring some of the gains from Tuesday, the stock’s best trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results